multiple myeloma
Showing NaN - NaN of 102
Multiple Myeloma, Relapsed Hematologic Malignancy Trial in Seattle (Digital Health Coaching Program, Fitbit)
Recruiting
- Multiple Myeloma
- Relapsed Hematologic Malignancy
- Digital Health Coaching Program
- Fitbit
-
Seattle, WashingtonUniversity of Washington
Jul 13, 2023
Acute Lymphoblastic Leukemia, Adult B-Cell, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in United States (clonoSEQ
Recruiting
- Acute Lymphoblastic Leukemia, Adult B-Cell
- +3 more
- clonoSEQ Assay
-
Stanford, California
- +15 more
Jan 30, 2023
Multiple Myeloma Trial in Spain, United States (BB2121, CC-220, BMS-986405)
Recruiting
- Multiple Myeloma
- BB2121
- +2 more
-
Birmingham, Alabama
- +33 more
Jan 26, 2023
Multiple Myeloma Trial in United States (Lenalidomide, Daratumumab/rHuPH20)
Recruiting
- Multiple Myeloma
-
Anchorage, Alaska
- +698 more
Jan 24, 2023
Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)
Completed
- Multiple Myeloma
-
Birmingham, Alabama
- +60 more
Jan 24, 2023
Collection of Tissue Samples for Cancer Research
Recruiting
- Neoplasms
- +3 more
- Biopsy
-
Atlanta, Georgia
- +9 more
Jan 23, 2023
Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Pomalidomide)
Active, not recruiting
- Multiple Myeloma
- Teclistamab
- +5 more
-
Birmingham, Alabama
- +26 more
Jan 17, 2023
Multiple Myeloma Trial in Worldwide (Daratumumab IV, Lenalidomide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Daratumumab IV
- +3 more
-
Birmingham, Alabama
- +211 more
Jan 17, 2023
Multiple Myeloma Trial in Worldwide (Placebo, Ixazomib)
Blood Samples to Identify Biomarkers of Busulfan
Active, not recruiting
- Leukemia
- +4 more
-
Seattle, WashingtonUniversity of Washington
Jan 4, 2023
Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,
Recruiting
- Waldenstrom Macroglobulinemia
- +8 more
- Iopofosine I 131 single dose
- +2 more
-
Redlands, California
- +42 more
Dec 30, 2022
Multiple Myeloma Trial in Worldwide (bb2121, Daratumumab, Pomalidomide)
Active, not recruiting
- Multiple Myeloma
- bb2121
- +8 more
-
Birmingham, Alabama
- +59 more
Dec 13, 2022
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Crizotinib
- +17 more
-
Birmingham, Alabama
- +125 more
Nov 21, 2022
Multiple Myeloma Trial in Worldwide (ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone)
Active, not recruiting
- Multiple Myeloma
- ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone
-
Atlanta, Georgia
- +25 more
Aug 31, 2022